<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Delphian lymph node":1,
"lateral lymph node":1,
"papillary thyroid cancer":10,
"Thyroid cancer":23,
"lymph node classification":1,
"nodal metastasis":1,
"preoperative radiography":1,
"BRAF":6,
"PIK3CA":2,
"Papillary thyroid carcinoma":17,
"RET":1,
"Diameter":1,
"Prognosis":5,
"Recurrence":2,
"Volume":1,
"Breast cancer":11,
"Core needle biopsy":1,
"HER2":1,
"Hormone receptor":1,
"Ki-67":2,
"Molecular markers":1,
"guidelines":1,
"incidence rate":1,
"Cancer registry":1,
"China":2,
"Neoplasms":4,
"Population-based study":1,
"Survival rate":2,
"breast neoplasms":1,
"epidemiology":4,
"hepatitis B infection":1,
"hepatitis B surface antigens":1,
"pathology":5,
"Neuromonitoring":1,
"Recurrent laryngeal nerve":1,
"Surgery":2,
"Thyroid":5,
"Voice":2,
"Endoscopic thyroidectomy":1,
"Three-dimensional endoscopy":1,
"Achaete-scute homolog like 1":1,
"Carcinoma de célula pequeña":1,
"Cáncer de próstata":1,
"Diferenciación neuroendocrina":1,
"Factor de transcripción clase III/IV POU3F2":1,
"Factores de transcripición de desarrollo neural":1,
"Neural development transcription factors":1,
"Neuroendocrine differentiation":1,
"Prostate cancer":1,
"Small-cell carcinoma":1,
"Transcription factor class III/IV POU3F2":1,
"Competitive risk model":1,
"Peripheral dose":1,
"Risk assessment":2,
"Second primary cancer":2,
"Non-Hodgkin lymphoma":1,
"Renal cancer":1,
"Second cancer":1,
"Second malignant neoplasm":1,
"Meta-analysis":3,
"Open":1,
"Recurrence rate":1,
"Robotic":1,
"Thyroidectomy":10,
"18F-TFB":1,
"PET/CT":2,
"thyroid imaging":1,
"Melanoma":1,
"POT1":1,
"Telomere":1,
"dosimetry":1,
"radioactive iodine":1,
"therapy":1,
"Cervical Lymph Node Metastasis":2,
"Extrathyroidal Extension":1,
"Medullary Thyroid":1,
"Medullary Thyroid Carcinoma":3,
"calcification":1,
"egg shell":1,
"ring":1,
"thymoma":1,
"TgAb":2,
"differentiated thyroid carcinoma":2,
"high sensitive":1,
"outcome":1,
"thyroglobulin":3,
"Body fat ratio":1,
"Obesity":1,
"Roux-en-Y gastric bypass":1,
"Thyroid hormone":2,
"Thyroid tumors":1,
"Benign Thyroid Nodule":1,
"Bipolar Group":1,
"Percutaneous Ethanol Injection Therapy":1,
"Radio Frequency Ablation":1,
"Thyroid Nodule":6,
"K-TIRADS":1,
"Thyroid cancer, follicular":1,
"Ultrasonography":4,
"Mucoepidermoid carcinoma":1,
"Radioactive iodine treatment":1,
"Salivary gland carcinoma":1,
"Secondary carcinoma":1,
"RAS":2,
"EIF1AX":1,
"Familial nonmedullary thyroid carcinoma":1,
"TERT promoter mutations":1,
"Aged":1,
"Papillary thyroid microcarcinoma":3,
"Thyroid cancer, papillary":1,
"Treatment outcomes":1,
"Hyperthyroidism":1,
"Hypothyroidism":1,
"Acromegaly":1,
"IPMN":1,
"Pancreatic cysts":1,
"anaplastic thyroid carcinoma":2,
"atypical adenoma":1,
"epithelial-mesenchymal transition":1,
"frequency domain analysis":1,
"head and neck ultrasound":1,
"photoacoustic imaging":1,
"tissue characterization":1,
"RET protooncogene":1,
"multiple endocrine neoplasia type 2":2,
"phaeochromocytoma":1,
"Neoplasm staging":1,
"Thyroid neoplasms":8,
"Basal subtype":1,
"Metastatic cancer":1,
"Primary cancer":1,
"Radioresistance":1,
"McGill Thyroid Nodule Score":1,
"fine-needle aspiration biopsy":1,
"pediatric":3,
"thyroid nodules":3,
"thyroid ultrasound":1,
"well-differentiated thyroid carcinoma":1,
"Chernobyl nuclear accident":1,
"cohort studies":1,
"cross-sectional studies":1,
"radiation":2,
"BRCA1":1,
"BRCA2":1,
"Microfluidic PCR":1,
"Mutation":1,
"Next-generation sequencing":1,
"anti-thyroglobulin antibodies":1,
"interference":1,
"Endoscopic skull base":1,
"Lung cancer":1,
"Pituitary adenoma":1,
"Pituitary metastasis":1,
"Staging":1,
"Octamethylcyclotetrasiloxane":1,
"Oncogenicity":1,
"Siloxane":1,
"Biokinetics":1,
"Effective half-time":1,
"I-131":1,
"Retention rate":1,
"TSH stimulation":1,
"rhTSH":1,
"FVPTC":1,
"NIFTP":2,
"expression profile":1,
"nanoString":1,
"thyroid neoplasm":1,
"Radioiodine therapy":2,
"Recombinant human thyrotropin":1,
"Therapeutic response":1,
"Autophagy":1,
"EGFR":2,
"Gefitinib-resistance":1,
"HSP90":1,
"Honokiol":1,
"FNA":1,
"cytopathologist":1,
"ultrasound":3,
"Carcinoid tumor":1,
"Incidental":1,
"Intradural":1,
"Primary":1,
"Bethesda classification":1,
"atypia of undetermined significance":1,
"fine needle aspiration":1,
"follicular lesion of undetermined significance":1,
"ERK1/2 pathway":1,
"IL-17B":1,
"IL-17RB":1,
"Invasion":4,
"Metastasis":5,
"CT":1,
"imaging protocol":1,
"radiation dose reduction":1,
"radiation shielding":1,
"Bethesda":1,
"diagnostic value":1,
"fine needle aspiration biopsy":1,
"pre-Bethesda":1,
"histology":2,
"population study":1,
"size":1,
"variants":2,
"predictive genetic testing":1,
"lymph node metastasis":6,
"male":1,
"young age":1,
"miR-10a-5p":1,
"MicroRNA":1,
"renal cell carcinoma":1,
"spindle and kinetochore-associated protein 1":1,
"tyrosine kinase inhibitor resistance":1,
"D631Y mutation":1,
"medullary thyroid cancer":1,
"pheochromocytoma":1,
"Radiotherapy":2,
"external beam radiation":1,
"head and neck cancer":2,
"Neck Dissection":4,
"Epidemiologic studies":1,
"Health surveys":1,
"Registries":2,
"Reproducibility of results":1,
"Self report":1,
"Sensitivity and specificity":1,
"Cancer":4,
"Conditional survival":1,
"Population-based":2,
"Relative survival":1,
"SEER":3,
"BDE-209":1,
"BRAF V600E":2,
"Flame retardant chemicals":1,
"Tris(2-chloroethyl) phosphate (TCEP)":1,
"core-needle biopsy":2,
"fine-needle aspiration":2,
"malignancy rate":1,
"18F-FDG PET/CT":1,
"propensity score analysis":1,
"thyroid incidentalomas":1,
"FDG-PET/CT":1,
"TIRADS":1,
"follow-up":1,
"suspicious thyroid nodules":1,
"Japan":1,
"Pediatric papillary thyroid carcinoma":1,
"Sporadic thyroid cancer":1,
"Ukraine":1,
"Beta-catenin":1,
"Desmoid-type fibromatosis":1,
"Nodular fasciitis":1,
"Papillary carcinoma":2,
"Adult":2,
"Age distribution":1,
"Incidence":2,
"Mortality/trends":1,
"Neoplasms/epidemiology":1,
"Sex distribution":1,
"Sex factors":1,
"Time factors":1,
"Gender inequality":1,
"nuclear atypia":1,
"thyroid cytology":1,
"comprehensive lateral neck dissection":1,
"lateral neck dissection":1,
"persistent thyroid cancer":1,
"recurrent thyroid cancer":1,
"salvage neck dissection":1,
"well-differentiated thyroid cancer":2,
"General anesthesia":1,
"Local anesthesia":1,
"Monitored anesthesia care":1,
"Differentiated thyroid cancer":3,
"Dynamic risk stratification":1,
"cost analysis":1,
"molecular testing":1,
"CCL27":1,
"CCR10":1,
"ERK1/2":1,
"Migration":1,
"NIFTPs":1,
"follicular-patterned thyroid lesions":1,
"miRNAs":1,
"aspiration":1,
"diagnostic adequacy rate":1,
"fine-needle cytology":1,
"nonaspiration":1,
"suspicious lymph node":1,
"Hypercalcemia":1,
"Hyperparathyroidism":1,
"Hypocalcemia":1,
"Hypoparathyroidism":1,
"Angiogenesis":1,
"Bcl-2":1,
"Notch1":1,
"Thyroid carcinoma":11,
"VEGF":1,
"miR-34b":1,
"Gastric neoplasms":1,
"Population register":1,
"Second primary neoplasm":1,
"lower-risk thyroid cancer":1,
"outcomes":2,
"regional variation":1,
"treatments":1,
"Lymph nodes":1,
"mortality":1,
"neoplasm metastasis":2,
"Age":1,
"Descriptive epidemiology":1,
"Functional outcome":1,
"Nationwide study":1,
"Reconstruction":1,
"Sex":1,
"Trachea":1,
"Tracheostomy":1,
"GABRB2":1,
"Oncogene":1,
"Akt":1,
"MDM2":1,
"Proliferation":3,
"RasGRP3":1,
"Immunohistochemistry":4,
"Radioiodine":1,
"Thyroid autoimmunity":1,
"Lead":1,
"nodular goiter":1,
"thyroid adenoma":1,
"thyroid hormones":2,
"Carcinoma tiroides":1,
"Ganglio centinela":1,
"Metástasis ganglionar":1,
"Sentinel lymph node":1,
"conflicts of interest":1,
"ethics":1,
"overdiagnosis":1,
"public health":1,
"shared decision-making":1,
"treatment":2,
"NCoR":1,
"myeloid cell":1,
"premetastatic niche":1,
"retinoid X receptor":1,
"LKB1":1,
"YAP/TAZ":1,
"histone methylation":1,
"serine biosynthesis":1,
"E3 Ligase UBE4":1,
"Poly r(C) binding protein (PCBP) 1":1,
"Cancer du larynx":1,
"Cancer of the larynx":1,
"Carotid invasion":1,
"Envahissement carotide":1,
"Recurrent tumor":1,
"Récidive tumorale":1,
"Formalin-fixed":1,
"Paraffin-embedded":1,
"Tissue microarray":1,
"Tumorigenesis":2,
"cMYC":1,
"Chronic lymphocytic thyroiditis":1,
"PD-1":1,
"PD-L1":1,
"Tumor-infiltrating lymphocytes":1,
"biomarkers":1,
"cytology":1,
"diagnostic imaging":1,
"differential diagnosis":1,
"oncogenes":1,
"18":1,
"F-FDG":1,
"F-fluorodeoxyglucose":1,
"PET PET/CT":1,
"Thyroid incidentaloma":1,
"positron emission tomography":1,
"Bax":1,
"Bcl2":1,
"NVP-AUY922":1,
"dipeptidyl peptidase-IV inhibitor":1,
"gemigliptin":1,
"synergism":1,
"sphingosine kinase 1":1,
"GO ontology":1,
"KEGG pathways":1,
"differentially expressed genes":1,
"protein–protein interaction network":1,
"Decision-making":1,
"Diagnosis":2,
"Galectin-1":1,
"Peptides":1,
"Phage display":1,
"Ultrasmall superparamagnetic particles of iron oxide":1,
"Gastrinoma":1,
"Neuroendocrine tumours":1,
"Somatostatin":1,
"Somatostatin analogues":1,
"Environment temperature":1,
"cancer incidence rate":1,
"statistical analysis":1,
"high-mobility group A2":1,
"let-7b":1,
"microRNAs":1,
"Gefitinib":1,
"Vemurafenib":1,
"RET/PTC":1,
"TERT":1,
"distant metastasis":1,
"Case report":2,
"Cinacalcet":2,
"Ectopic calcification":1,
"Hemodialysis":1,
"Parathyroid carcinoma":2,
"Secondary hyperparathyroidism":1,
"Carcinoma, papillary":1,
"Intermuscular lymph node":1,
"Lymphoma":1,
"Radioiodine ablation":1,
"Growth suppression":1,
"PTEN":1,
"RBM38":1,
"mRNA stability":1,
"CXCL5":1,
"PDL1":1,
"drug resistance":1,
"p-eIF2α":1,
"triple-negative breast cancer":1,
"vascular endothelial growth factor":1,
"Deoxyglucose":1,
"Hypermetabolic thyroid nodules":1,
"Tomography, X-ray computed":1,
"Tomography, emission-computed":1,
"Fiducial markers":1,
"Neoplasm recurrence, local":1,
"Austria":1,
"Cohort study":1,
"Relative risk":1,
"Retrospective":1,
"Completion surgery":1,
"Lymph node dissection":1,
"gynecological cancer":1,
"oncology":2,
"Central lymph node metastasis":1,
"Lateral lymph node metastasis":1,
"Risk factors":1,
"Skip metastasis":1,
"General Practice / Family Medicine":1,
"Thyroid Disease":1,
"MRI outcomes":1,
"NEDA":1,
"alemtuzumab":1,
"annualized relapse rate":1,
"autoimmune event":1,
"infusion-associated reaction":1,
"multiple sclerosis":1,
"no evidence of disease activity":1,
"risk mitigation":1,
"HIF-1α/ HIF-2α/ vitamin C/GLUT1/ thyroid cancer":1,
"AP-2α":1,
"Cholangiocarcinoma":1,
"EMT":1,
"MAPK7":1,
"TGF-β":1,
"miR-200b":1,
"adiposity":1,
"children":3,
"iodine":1,
"thyroid nodule(s)":1,
"proline rich 11":1,
"tongue squamous cell carcinoma":1,
"Imaging":1,
"Radiotracers":1,
"tuberous sclerosis":1,
"Causative variant":1,
"Gene panel":1,
"Hereditary breast cancer":1,
"NGS":1,
"MALAT1":1,
"MiR-21":1,
"siRNA":1,
"Fine needle aspiration cytology":1,
"pitfalls":1,
"2017":1,
"Alkaline phosphatase":1,
"Bisphosphonates":1,
"Bone pain":1,
"CT scan":1,
"Calcium (serum)":1,
"Calcium carbonate":1,
"Capecitabine":1,
"Endocrine-related cancer":1,
"Fatigue":1,
"Female":1,
"Fluid repletion":1,
"Fluorouracil":1,
"Furosemide":1,
"Greece":1,
"Histopathology":1,
"Hypercalcaemia":1,
"Hypophosphataemia":1,
"Lymphadenectomy":1,
"MRI":1,
"Metastatic carcinoma":1,
"Myasthaenia":1,
"October":1,
"PTH":1,
"Pamidronate":1,
"Parathyroid":1,
"Parathyroid hormone":1,
"Parathyroidectomy":1,
"Phosphate (serum)":1,
"Polydipsia":1,
"Polyuria":1,
"Radionuclide imaging":1,
"Sestamibi scan":1,
"Temozolomide":1,
"Ultrasound scan":1,
"Unique/unexpected symptoms or presentations of a disease":1,
"White":1,
"Zoledronic acid":1,
"cyclin-dependent kinase 8 (CDK8)":1,
"miR-148a":1,
"papillary thyroid carcinoma (PTC)":2,
"TSH":1,
"gonadal hormones":1,
"thyroid-stimulating hormone repressive therapy":1,
"Stage thyroidectomy":1,
"bilateral injury":1,
"intraoperative neuromonitoring (IONM)":1,
"recurrent laryngeal nerve (RLN)":1,
"thyroid surgery":1,
"complications":1,
"tracheal resection":1,
"neoplasm recurrence":1,
"skin":1,
"Thoracic duct":1,
"single port":1,
"thoracoscopic approach":1,
"familial adenomatous polyposis (FAP)":1,
"genetic testing":1,
"hereditary nonpolyposis colorectal cancer (HNPCC)":1,
"multiple endocrine neoplasms":1,
"cartilages of larynx":1,
"larynx stenosis":1,
"open partial laryngectomy":1,
"piezoelectric knife":1,
"MAP kinase signaling system":1,
"cancer stem cells":1,
"phosphortidylinositol-3 kinase":1,
"sonic hedgehog":1,
"Clinicopathologic characteristics":1,
"Hashimoto’s thyroiditis":1,
"Blurred or/and partially missing boundaries":1,
"Compact shapes":1,
"Isoperimetric constraint":1,
"Lesion segmentation":1,
"Level set":1,
"BRAF mutation":1,
"UNC5D":1,
"tumor-suppressive function":1,
"BRAFV600E mutation":1,
"efficacy":1,
"radioiodine remnant ablation":1,
"PSM":1,
"T2DM":1,
"TC":1,
"overall survival":3,
"TP53":1,
"breast invasive carcinoma":1,
"driver mutation":1,
"insular thyroid carcinoma":1,
"propensity score matching":1,
"lobular carcinoma in situ":1,
"lumpectomy":1,
"mastectomy":1,
"Anaplastic transformation":1,
"Long-term survival":1,
"Pulmonary metastasis":1,
"Cytokeratin":1,
"isolated skeletal muscle metastasis":1,
"nonsmall cell lung carcinoma":1,
"parathyroid hormone-related peptide":1,
"progression-free survival":1,
"superior vena cava":1,
"thyroid transcription factor":1,
"Follicular thyroid carcinoma":1,
"histopathological types":1,
"anterior chest wall":1,
"cirrhosis":1,
"hepatitis C virus":1,
"hepatocellular carcinoma":2,
"Blood Coagulation Factors":1,
"Fibrinolysis":1,
"Receptor, Thyroid Hormone":1,
"Venous Thromboembolism":1,
"gas chromatography-time-of-flight mass spectrometry":1,
"laryngeal squamous cell carcinoma":1,
"metabolomics":1,
"ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry":1,
"Decision-making experience":1,
"Decision-making preference":1,
"Psychological distress":1,
"ABCB1":1,
"FTH1P3":1,
"miR-206":1,
"paclitaxel resistance":1,
"Jordan":1,
"adolescents":1,
"registry":1,
"survival":1,
"Adenocarcinoma of lung":1,
"Napsin A":1,
"Occult cancer":1,
"Ovarian clear-cell carcinoma":1,
"AREG":1,
"Cell viability":1,
"T3":1,
"miR-204":1,
"calcitonin":1,
"calcium-stimulated test":1,
"markers":1,
"Diabetes":1,
"Glucose/galactose malabsorption":1,
"Sodium glucose cotransporters":1,
"Solute carriers":1,
"Metabolism":1,
"Pyruvate kinase":1,
"Radiation therapy":1,
"Follicular variant":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"histologic subtype":1,
"parotid metastasis":1,
"bone metastasis":1,
"genetic heterogeneity":1,
"next generation sequencing":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年10月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO4AAADICAYAAADvG90JAAAWNElEQVR4Xu2dedS/5ZzHX/6YmVJRKi1ojwqjydaqIilJacgkhFSYM5UkSyiFSpaypIXRiJBjyJqTZBjLjL2hxZpMRqEkSxznzJz3dH1PT0/P83zv5bqv5b7fn3O+5+l3uu/r8/m8r/t9L9f1We6GxQgYgeoQuFt1FttgI2AEMHF9ERiBChEwcSucNJtsBExcXwNGoEIETNwKJ80mGwET19dAbAS2BDYNv/sA9wLWAtYEVpuj7M/Ab8LvZuB64Mrw+3lsQ2sez8Stefby2r4TsBtw/wVEve+AJv0C+BxwOfAZ4GcD6ip+aBO3+CkqxsB1gKcBewK7Aqtntuwa4JPA24CfZLYluXoTNznkVSlcA/h74OnAYwq2/ELgNcBVBdsY1TQTNyqcoxnsAcAxgbB3r8grvUafCVxckc2dTDVxO8E22pM2CRf+Eyv38EvAUcA3KvdjWfNN3LHObHu/TgJe2f60os/Q6/PYfPp/wE3coq+7JMZtD7wf0NN2jPKFsKimraXSZGNgL+BfgNvaGGfitkFrfMe+FDhlfG7dxaNbgBcAWsTKLdrXfirwDGAH4BHA19oaZeK2RWwcx2vB6WOFrxQPgfR5wOFDDDxnTAWePBn4h/CEnR1+EPCBLvYMQdytp7Qs3wX0As5RIMPuBdiRw4QvA/uE6Kyh9e8NHBy21FZZpExrCid0NWAI4upOrjvM/sCtXQ3zeYMhoK2S2leN+4KjMMpdgJv6DrTE+YooU6CKnqYK9VxKPgQc2Ed3bOJuGOJLZdN3wmuBQtUsZSBwLnBYGaZkt+KK8NYRg7wK+3xm+G7daI5nXwce3tf72MQ9GnjzAqO0krcHcHVfQ31+bwQOAD7ce5RxDaCHi67PX3Vwa/0QoKJX4W0bnq/46ocCv2x4/LKHxSbuUt9OyvJ4PPDVvsb6/M4IKPj/v0KGTudBRnqiyKstsSbbMfcMC0xaFW67RqDxHwnoSd9bYhJ3XeDGZSz6Y3BY37+W9AhcBjw6vdpqNCrS6uSQdbSU0SLpc8O3a1en9gU+0fXkxefFJO6hwDvnGPY84JxYxnucRggcApzf6EgfpLfD2RPxr4ENIgWmHAu8MSa8MYnbdLXydcDxMZ3wWMsisCrwY0DfY5Y8CLwbeE5s1TGJ+78tjNNyuFbhmnxXtBjWhy5C4MQ+e4VGszcCegXfufcoSwwQi7jK1fxsSwMV5qX3/htanufDmyGwXkgw11PXkh4BJfdrBVmv39ElFnFPB/Qe31ZUR+hxwHfbnujj5yLwcuC1c4/yAUMg8NuwV/v9IQbXmLGIq62GB3U08vdhtc4rzh0BXOY0VYPYKu6QHq0hAtob1kr+YBKDuMp2+HUEC18GnBphHA9x+yuaInQs6RFQZNq83ZXeVsUgruJeY5UK6R3D2RuRcQxwRqgAMQ5v6vFCuL8whbkxiHsacFxEYxVhtd8KwRwRVY12KMWHa3HKkg6BSwBlAyWRGMRVhQFlWsQUXXgi73/GHHQiYz3Qi33JZ1rZRgpn/F0qzTGIq8WloSoBvgh4UyowRqLn+cBZI/GlBjeUoPAw4Kc9jd0GUHVNBcwofnpF6UtcKRo680erzcpv1A3CMh8BVVRQELwlDQJtSs8oSUG7L1rtF3dmf5UWKGm8xtOXuE8BLkqAj6rWKzF/6JtEAlcGV/E/DnEcHOOZAj1QVGhvsYiIWwSSiqD6t56o2oFZTrQS3ThXui9xXwW8OhFMeuIq5jPFjSKRS9HVbA78MPqoHnApBPQJp/xmkVK/Bweydtk7f0vbXYC+xNXdRgWwUkprJ1Mal1mXFvQ+mtkGq2+HgGIXFMPQSvoSV5Xit2ulMc7B3wrfcT+IM9xoRlHbkKjpY6NBpkxHVKxdRdtbS1/iql7tPVprjXOCkvO16vyOOMONYhStJmtV2VI+AgrUUMBGJ+lDXK2QqQlxblGrRSWLxwi7zO1LX/3qG6s2mJayEdDN9ew+JvYhrlbNSnlVVckcrfANGtjdB+hE5/4I2CyRLqvphoBalr6v26l3nNWHuIoUKa0AnJoc/1NfUCo+v00xg4rdrNZ07a9H2RXpQ9xHAf9WIIR6C1B1jdJuKimgMnFToNxNhyqdfrrbqXc9qw9x1bBI7RxKFRWle/GEuilokVCLhZbyEIien9uHuKrGXnoSgJIVjggNrsqbzrgW3dtlgOICGmE01VRTxtDnI4x1pyH6EPdvmwRDxza443iKcFGbxeXqPncctqjT7gdcV5RF0zZG5WtUlmmQT7Y+xFVol8qj1CICUnnDY63rXNIqfy3XxFB26pNFBei/OZSCPsRVrV4FtNcmAlPB3IOBmgkQ5+FmAn6RWsUTaOFWObqDSR/iyqiaVzHVue4lhQSRxJjgmj5dYvhb4hh6kKldibLZBpW+xFXy8Ly2goM60HNwtVhUGdMxvD4rz1PVNi15EFAnvl1DLevBLehLXIUban+qdtHq+FFDLSQkAidFUYNErlSnRrEDetKqrWwS6Utc9QFqnZKUxLNuSnQjUsaGso9qk01S3e1rA2Zge/UtK9Im3bHoS1xtLF86MDA5hv/XQOBBFxgiO7ZSm9PIqjxcQODbgNrvxOhq3wrUvsRVX5o/tNJY18EXhgofg7WSiAjH6hOKEosIW+ehRNZNAW0zJpe+xJXBCppW7akxi4p4nVLBK3TNq/y1XT9ajMq2MBuDuDsCaic4Bbk8lIuN1lk8MmgmbmRAVxhOZVn1eZJFYhBXhmvfalZiMosjiZWqu+CZgEqhJiuC3cBH2bJag+N8SH8EVLxQnydZJBZxp1qEW9/3Ks72HkDVJ3LLL4F1chsxIf2x+NMasliKVwGunXi/GpFGBP4goKbdOURJBko2sKRBIBZ/WlsbU7Gyb97e2oJxnqCbmMqT6FU6ZdNurX5vOU5Ii/RKrXdUtDC5xCSujFffEy2RW+5AQHvBWpX+SII0yCtCYW7jnwYBFS+4NY2qO2uJTVwVR1+qJUMO30rUqS4DIrD6If37AAb+B6BeNpY0CKyZq+pIbOIKLnVCV0d0y3wEVLNLW2lfDNVE+kbgaDyllFnSILB2jqgpuTYEcUus/phmGvtr0aa+4qT10z6hcju16KW/ioVdKYhdscp6JVfLR0saBNQ8PGmM8sytIYirsY/v2lohDd7WYgSiIKA6X7qxJpehiCtHvgJsn9wjKzQC6RBQ28yb06m7Q9OQxNV+orZCcvUWyoGndU4LAbXhqTbJYKWp2gcoNa53WpeYvR0CAYWXZsmOG/KJOwNKja/VANtiBMaGQAr+LIlZKsVKTH/S2GbN/kwegVT8uQvQXRQfCagrfFvRXuXObU/y8UagUASUibVGLtvaEndWZUElO5Q8r0igpiInFTG0W9MTfJwRKBiBGwDVFs8ibYm7MGle+YhHA+9sablCIhUaaTECNSOgXsTqHpFF2hL3ucB5iyxVaVPl47bpDHAicEIWj63UCMRB4DvAtnGGaj9KW+KeFvrvLKXpvaEuU9PKiAcAFwBKjbIYgdoQUJLILrmMbktckfPgOcZ+FjgbUIe8eaLcUWXLqO+NxQjUhIDWa/bLZXBb4l4SWgc2sVcf76oIIWIq/HE50RP3WOAYQJEoFiNQAwL/DByay9C2xNX3rBpatxU1Q7osEFhlXX4Ssl80jkIj1bBKokZcG7Yd3McbgQwIvD40jcugun1an5pKqbmUxQhMHQH1Wj49Fwhtn7haeNo6l7HWawQKQuA5wLtz2dOWuAq8eEguY63XCBSEwN6A1nyySFviuqZRlmmy0gIR0LpMtn7EbYmrrR51J7MYgakjkC2JXsC3Ja6KfR849Rmz/0agA3eigtaWuCp4rsLnFiMwZQTUgT5rr6y2xFWgRLYl8ClfKfa9KAT0yfjYnBa1Je4TgI/nNNi6jUABCCikV4k12aQtcVW7V1FPFiMwZQT05vnGnAC0Ja5sVQyy6slajMBUEdgfuDin812IK4OfmNNo6zYCmRFQ2O/3ctrQhbhHAWfkNNq6jUBmBFYFbstpQxfiqo2m2mlajMAUEbgG2Cq3412IK5tVtmOWipfbB+s3AikRUGO17EFIXYmrInFvTomWdRmBQhB4ZQkN7boSV5UqflMIkDbDCKREIPuKspztSlyd+y5AOYkWIzAlBDYGrsvtcB/ibgaotqzFCEwFATUbX7cEZ/sQV/afAxxegiO2wQgkQEDhvkXEMPQl7gaAMiXUbtBiBMaOQBELU32/cWeTpDQ/pftZjMDYEdgTuLQEJ/s+cWc+fBnYoQSHbIMRGBCBbB3oF/sUi7haafsuoG5+FiMwRgS+BWxXimOxiCt/9g1tNEvxzXYYgZgIKOBI3TaKkJjElUOvBV5ehGc2wgjEReBJwEfjDtl9tNjElSVn5a4O0B0On2kElkVgbeCmUvAZgrjy7UzgyFKctB1GoCcCRX3fypehiKux9cqsV2eLEagdgZOBV5XkxJDElZ+7AkqDKiJMrCTgbUtVCDwSUKfKYmRo4srR9UPn+T2K8dqGGIHmCBQTn7zQ5BTEnelTE2BVxnPz6uYXjY/Mj4A68hWXBZeSuJoCNa3WqvN++efDFhiBRggoqaC4WuKpiTtDavtQRcANxBpdOz4oEwK3AvfIpHtFtbmIOzNqF+DVwO4lgmObJo/Ae4BDSkQhN3FnmGwR8nqf5RXoEi+TydqkMN5PlOh9KcRdiM1BIe55N0D5vhYjkAOBW4A1cyhuorNE4i60W60MtRcsEu8MbNTEKR9jBCIgcC5wRIRxBhmidOIudlo9i3YMub9a4HoYcPdBkPGgU0dgJ0B55kVKbcRdCKIIrJhokddiBGIioCKIWncpVmojrkInDwAOBrQibTECQyBQTG2p5ZzLQdxtgFeE0q7XAj8F/rKMgSKqgjY2D9+6bnsyxGXqMRcjUETt5JWmJQdxtVJ3s68VI1AoAh8Jb3WFmne7WTmIK71fBZRxYTECpSGgXYwvlGbUYntyEfc44LTSwbF9k0PgKkCfcsVLLuK6x27xl8YkDXw2cH4NnucirrD5YgiqqAEn2zh+BIrMu10O9pzEPQxQdIrFCJSAwLEhX7wEW+bakJO4qwLXA2vNtdIHGIFhEVCv5/sBvxtWTbzRcxJXXiilr6giXPGg9UgVIXAScEJF9mbbDpphtE4IwHC8cU1Xzbhs/UNIXvl1TW7lfuIKK4WX6Y5nMQI5ENAbn8qvViUlEFe9dRXUvV5VyNnYMSBwI7AZ8PvanCmBuMJMxeOK6ctS2yTa3s4IPA84p/PZGU8shbiC4EJA1S8sRiAFAlcDW6dQNISOkoir5IMrXa5miGn2mEsgsBfwmVqRKYm4wnDbUHVAe7wWIzAUAh+rvbZ3acTVRKkA9cVDzZjHNQJh++dnNSNRInGF50uAU2sG1rYXi4A6SKqQQ9VSKnEF6hnAUVWja+NLQ0Dbjg8CbivNsLb2lExc+aKGSyqSbjECMRB4BPC1GAPlHqN04gqfC4Cn5wbK+qtH4A3Ai6v3IjhQA3Fl6vGhSdhYcLcfaREovtxqWzhqIa78UnSVgjSckNB2ln383wHfHhMMNRFXuD8YuAjYakyTYF8GRaCqBPmmSNRG3Jlf6mBwZFMnfdxkEbgM2GOM3tdKXM2FmmLr1Vn9hCxGYDECqiGlWGT9HZ3UTFxNhrqFK59Xr0MWI7AQgSrqI3edstqJO/Nb9YJOB57aFQifNyoEqkyObzMDYyHuzGd17jsR2KcNCD52VAhcCuw5Ko+WcGZsxJ25+ADgaOCZ3j4a+yV8J/9+HjoRqJv8qGWsxJ1Nmkq/Hgqo0oE6/lnGi4Aaye0ccrrH62XwbOzEXTiBegrvG36PGv3MTstBVWrcbSxxyE2mbkrEXYjHPYH9Q8/dHRzQ0eRSKfqYRwOXF21hZOOmStzFMIrIOwHbAzuGFqCrR8baww2DgAovfHyYocsd1cRdem5eP6ZMknIvv96WPQN4b+9RKhzAxL3rpGkrodoiYhVeg11N/kfgrK4n136eiXvnGdwF+DSgIu2WchHQXr36Tk1WTNw7pl6rkiLtKpO9GupwXBFyx9Vh6nBWmri3Y/sC4O3DweyRIyGguPTXRBqr6mGmTlzt7X4QeEjVszgN4xUJp3ROC2Rvs5lzEp4citF52yfnLDTTfThwXrNDp3HUFJ+42qt9HbD7NKa4ai/VRU832Euq9mIA46dEXNWs0uuWFqEs5SPw38DjphJ73HY6xk7c+wDPDokGm7QFx8dnQ+ArIaa8qi7xKdEaK3EVUSPC+nU45dUUR5eCKhRcYVkBgTERVxUglTjwfLfqrPaa1832/GqtT2h4zcRVfWUVjHtseK3yq3DCCyeyquvDTffrkccd7XC1EVcFwPT6qzQuhSda6kfgU8AhY63GONT0lEpcVW/cBrg/oCAJJb6ruoFlPAj8ETgGOHs8LqXzpATibgpsBqiTmoq96e9900FgTRkQUMe8gwD19LF0QCAFcbcIRBRBNw6/jQJZ/V3aYdIqP0VNpdVc2tIDgT7EVdWIDcMKruoaa89UPz0t1wdE1HV72OZTx4XAN8K37PfG5VYeb1Yirkj4ImANQPG8+qtvzxlZ3TUvz5zVqPVlwKk1Gl6qzfOeuNoXVVf4NUt1wHYVjcDnQjDF1UVbWaFx84grl9YJmRkiscUINEHgupDsrpRJywAINCHuTO2zgLeG1+YBTPGQI0BA9Y1PcbL78DPZhriyRqvCenV2DPDwc1OThtuAc8Nq8Y01GV6rrW2JO/NTkS5vAu5Vq+O2OxoCCqA4GVDfHksiBLoSV+ZphfmlwAtdYC3RbJWl5m1hpVhxxpbECPQh7szU9YCTAJUXsYwbAb0SK+1OBeNvGLerZXsXg7gzDxVwoYgYhbJZxoXAb0MVzDcAN43LtTq9iUncGQJKDlDB6qfUCYmtXoDAr4Azwm6CyGspBIEhiDtzTYkD+gY+rBBfbUZzBBT8r6erM3eaY5b0yCGJO3NE8coKnVTRcYVNWspF4DLgXcD7yzXRlgmBFMSdIa14Z3WG1yq04p0tZSDwTeB9oeud92DLmJO5VqQk7kJjjgCODMnyc430AdER+CHwAeAC4PvRR/eAgyOQi7gzx5Q4r1BKrUQ7mGPY6Vb88EWBsEqxs1SMQG7iLoTuwJCv+fiK8SzN9F8EsoqwXyrNONvTHYGSiDvzQnm+qmC/L7APcO/u7k3yTO2zfjg8WZVWZxkhAiUSdzHMOwQC7w1sN8I5iOGSvlkvBy4GPhljQI9RNgI1EHchgmsDe4Un8p6Awi2nKD8APr/g5wD/iV0FtRF38fQ8FNgJ0FNZP6UdjlFmT9QZWU3UMc5yC59qJ+5iV/U9LCLvCDw81GXeoAUeuQ/Vk/Qq4BpA5V709wrg1tyGWX9ZCIyNuEuhuyqwJaAysZuHvwrHVDVKkVrVKlOJYn/VPlI/pcNdG/ZRRdIrUxlhPfUjMAXizpulVUJZWZFYP0V1rQWsFvKM/yb81XGz318Bfwo/pbrN/lt/Z/++ZRFJXfx73kz4/zdGwMRtDJUPNALlIGDiljMXtsQINEbAxG0MlQ80AuUgYOKWMxe2xAg0RsDEbQyVDzQC5SBg4pYzF7bECDRG4P8A3SKu5/rwGYoAAAAASUVORK5CYII=';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
